We tested whether quantitative transport mapping (QTM)‐derived perfusion velocity would detect earlier and more sex‐specific microvascular alterations than cerebral blood flow (CBF) across the Alzheimer's disease (AD) continuum.
While both Alzheimer's disease (AD) and cerebral small vessel disease (CSVD) involve vascular dysfunction, the ocular microvascular differences between them remain largely underinvestigated.
Zi-Yi Zhang, Le Cao, Peng Liu et al.· Alzheimer's & Dementia· 0 citations
Amyloid positivity does not reliably predict near‐term cognitive decline in preclinical Alzheimer's disease (AD). We tested whether digital cognitive phenotyping improves prognostic precision.
C. Vanderlip, C. Stark· Alzheimer's & Dementia· 1 citation
Participants with healthier patterns of brain blood flow and oxygen regulation had lower amyloid burden, reinforcing the idea that vascular function may be linked to Alzheimer's-related changes.
Cholinergic white matter pathway degeneration is central in Alzheimer's disease and Lewy body disease and can be assessed in vivo using magnetic resonance imaging proxies, but neuropathological validation is limited.
F. López-González, M. Němý, C. Jerele et al.· Alzheimer's & Dementia· 0 citations
The adiposity–cognition relationship in aging is controversial. This study aimed to assess its sex‐ and age‐specific associations with Alzheimer’s disease (AD) pathology using multimodal biomarkers.
Jing-Jing Zhang, Dan Liu, Yue-Ran Yang et al.· Alzheimer's & Dementia· 0 citations
Brain microvascular differences in older adults at rest are examined to find neighborhood deprivation is associated with reduced cerebrovascular reactivity and these findings are independent of Alzheimer’s disease-related pathology.
K. W. Law, A. Engstrom, T. Lohman et al.· Cerebral Circulation - Cogni...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.